会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • MASS TRANSFER SYSTEM FOR STABILIZING AN AIRSHIP AND OTHER VEHICLES SUBJECT TO PITCH AND ROLL MOMENTS
    • 用于稳定航空和其他车辆的大型转移系统受桩和车轮的影响
    • US20070095975A1
    • 2007-05-03
    • US11608198
    • 2006-12-07
    • Michael WaldenGeorge Heaven
    • Michael WaldenGeorge Heaven
    • B64B1/02
    • B64B1/70
    • The invention relates to a mechanism to control the pitch and/or roll and/or center of gravity of a vehicle. The first embodiment is a track-based mass transfer system in which pathways are positioned along or radially terminate at a central horizontal plane of the vehicle to move one or more mass transfer devices to a desired location to control the pitch and/or roll and/or center of gravity of the vehicle. A second embodiment is a fluid mass distribution system in which one or more conduits selectively distribute a fluid to one or more tanks positioned near a central horizontal plane of the vehicle to control the pitch and/or roll and/or center of gravity of the vehicle.
    • 本发明涉及一种用于控制车辆的俯仰和/或滚动和/或重心的机构。 第一实施例是基于轨道的质量传递系统,其中通路沿着或径向终止于车辆的中心水平面,以将一个或多个传质装置移动到期望的位置以控制俯仰和/或滚动和/ 或车辆的重心。 第二实施例是一种流体质量分配系统,其中一个或多个管道选择性地将流体分配到位于车辆的中心水平面附近的一个或多个罐,以控制车辆的俯仰和/或侧倾和/或重心 。
    • 3. 发明申请
    • Method and markers for the diagnosis of renal diseases
    • 用于诊断肾脏疾病的方法和标记
    • US20060286602A1
    • 2006-12-21
    • US11126385
    • 2005-05-10
    • Harald MischakThorsten KaiserStefan WittkeMichael Walden
    • Harald MischakThorsten KaiserStefan WittkeMichael Walden
    • G01N33/53
    • G01N33/6893G01N2800/347
    • Certain embodiments of the invention relate to means and methods for the diagnosis of a renal disease, particularly to differential diagnosis. Renal diseases of particular interest in the context of the invention are IgA-nephropathy, membranous glomerulonephritis (MGN), minimal-change-disease (MCD), focal segemental glomerulosclerosis (FSGS), and diabetic nephropathy. Particularly, the method comprises (a) measuring the presence or the absence of a polypeptide marker in a urine sample, wherein the polypeptide marker is selected from the group of polypeptide markers shown in tables 1 to 22, and (b) comparing the probability of the presence of this marker in a disease patient to the probability of the presence of this marker in a control patient, wherein the individual probabilities are as indicated in the tables, and wherein (c1) if the probability of the presence of this marker in a disease patient is higher than the probability of the presence of this marker in a control patient, the presence of this marker is indicative for a higher probability of having the disease, or (c2) if the probability of the presence of this marker in a disease patient is lower than the probability of the presence of this marker in a control patient, the absence of the marker is indicative for a higher probability of having the disease.
    • 本发明的某些实施例涉及用于诊断肾脏疾病的方法和方法,特别是鉴别诊断。 在本发明的上下文中特别感兴趣的肾脏疾病是IgA肾病,膜性肾小球性肾炎(MGN),微小变化疾病(MCD),局灶性肾小球硬化症(FSGS)和糖尿病性肾病。 特别地,该方法包括(a)测量尿样中多肽标记的存在或不存在,其中多肽标记选自表1至22所示的多肽标记组,和(b)比较 疾病患者中该标记物存在于对照患者中存在该标志物的可能性,其中个体概率如表中所示,并且其中(c1)如果该标志物存在于 疾病患者高于对照患者中该标志物存在的可能性,该标志物的存在表明患有该疾病的概率较高,或(c2)如果该疾病存在该标志物的可能性 患者低于对照患者中该标志物存在的可能性,则不存在标志物指示患有该疾病的可能性更高。
    • 5. 发明申请
    • CANNABIS CHAIN OF CUSTODY MANAGEMENT
    • 监督管理委员会
    • US20150278757A1
    • 2015-10-01
    • US14663373
    • 2015-03-19
    • Michael Walden
    • Michael Walden
    • G06Q10/08C07D311/80
    • G06Q10/0838C07D311/80
    • A method and system of managing a chain of custody for cannabis is provided that includes depositing one or more identification tags onto the surface of one or more cannabis seeds at a first custodian location, and depositing the identification tags onto the surface of one or more cannabis, wherein the cannabis plants are grown and matured from the cannabis seeds. The method and system further includes receiving the tagged cannabis plants at a second custodian location and extracting cannabinoids from the tagged cannabis plants, wherein the extracted cannabinoids include the one or more identification tags. In addition, the method and system further includes receiving the extracted cannabinoids at a third custodian location, wherein the extracted cannabinoids include the one or more identification tags which may be accumulated from all the prior custodians. Here, the first custodian location can include a seed grower or harvesting facility, the second custodian location can include a processing facility, and the third custodian location can include a distribution, retailer, merchant, sub-manufacturer of food products.
    • 提供了管理大麻监管链的方法和系统,其包括在第一保管地点将一个或多个识别标签放置在一个或多个大麻种子的表面上,并将识别标签沉积在一个或多个大麻的表面上 其中大麻植物从大麻种子生长和成熟。 该方法和系统还包括在第二保管地点接收标记的大麻植物,并从标记的大麻植物中提取大麻素,其中提取的大麻素包括一个或多个鉴定标签。 此外,所述方法和系统还包括在第三托管位置接收提取的大麻素,其中提取的大麻素包括可以从所有先前保管人积聚的一个或多个识别标签。 这里,第一保管地点可以包括种子种植者或收获设施,第二保管地点可以包括处理设施,第三托管人的位置可以包括分销商,零售商,商家,食品副产品。